The Institutional International Equity Portfolio OCSE:NOVO B Holdings History
The Institutional International Equity Portfolio's Novo Nordisk AS Holding Summary
As of 2025-03-31, HC CAPITAL TRUST held 65,458.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr4.48 Mil. This investment constitutes 1.14% of their stock portfolio, and HC CAPITAL TRUST now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q3. And since then The Institutional International Equity Portfolio has made 2 purchases of OCSE:NOVO B, at an average price of kr172.55, for a total of 600,053.00 shares. In addition, there have been 15 sales at an average price of kr267.39 for 534,595.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, The Institutional International Equity Portfolio's estimated gain on his OCSE:NOVO B holdings is kr66.54 Mil, reflecting a 64.27% gain to date.
The Institutional International Equity Portfolio OCSE:NOVO B (kr414.60) Holding Chart
The Institutional International Equity Portfolio OCSE:NOVO B (kr414.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
